28D-24199-40398
3 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 329 / FL
- Registered
- 2022-02-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-05-08
Dose 2 — Pfizer-BioNTech
-
2021-12-28
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-02-13
Registered in v-safe
-
2022-02-13
Survey response — day 42, dose 3MedDRA: Chest pain, Chills, Cough, Inflammation, Migraine, Nausea, Pain, Pyrexia, Respiratory tract congestion, Rhinalgia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Body aches, chills, fever, congestion, inflammation, sore nose, sore chest, cough, migraine, nauseaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | No |
| 2 | 2021-05-08 | Pfizer-BioNTech | No |
| 3 | 2021-12-28 | Pfizer-BioNTech | Flu |
Free text
Release 11 — day 42, dose 3
Symptoms: Body aches, chills, fever, congestion, inflammation, sore nose, sore chest, cough, migraine, nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinalgia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release